Type 2 Diabetes, Arterial Hypertension and Cardiac Complications

Abstract

Diabetes mellitus (DM) is one of the most common chronic diseases and represents a serious public health problem, as with diabetes, there is a decline in the quality of life, early disability and high mortality. Analysis of the results of the United Kingdom Prospective Diabetic Study (UKPDS) showed that increasing glycated hemoglobin levels by only 1% increases the risk of death associated with diabetes by 21%, myocardial infarction by 14%, peripheral vascular disease by 43%, microvascular complications - by 37%, development of cataracts - by 19%. The ONTARGET program, which examines the effects of blockade of RAAS using telmisartan on many components of the cardiovascular continuum, and which is expected to end in 2008, will provide new data on the results of treatment of patients with cardiovascular diseases and diabetes.